Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation
Annals of Clinical and Translational Neurology · 2026
DOI: 10.1002/acn3.70407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2026. Verfasst von Enrique Gonzalez Saez-Diez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorders Program, Department of Neurology & F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Mas…. Hauptthemen laut MEDLINE: Autoimmune Diseases of the Nervous System, Nervous System Malformations, Movement Disorders, Immunomodulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7. GMFCS levels ranged from I to V. Following immunomodulation, interferon signatures normalized in 6/7 of patients, and 6/7 showed clinical stabilization or improvement, with no further regression events. These findings indicate that targeted therapy was associated with reduced systemic inflammation and stabilized disease. However, motor outcomes varied, suggesting that established CNS injury may limit functional recovery despite a biochemical response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Movement Disorders Program, Department of Neurology & F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Medical Faculty, Heidelberg University, Heidelberg, Germany.
- Division of Neurology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of Immunology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Neuroimmunology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Spastic Paraplegia-Centers of Excellence Research Network (SP-CERN), Boston Children's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Enrique Gonzalez Saez-Diez, Monica Ferrer Socorro, Kathryn Yang, Adeline Vanderver, Milena M Andzelm, Darius Ebrahimi-Fakhari
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Gonzalez Saez-Diez, E., Ferrer Socorro, M., Yang, K., Battaglia, N., Zaman, Z., Bennett, M., Vanderver, A., Lee, P. Y., Henderson, L. A., Andzelm, M. M., & Ebrahimi-Fakhari, D. (2026). Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70407
Vancouver
Gonzalez Saez-Diez E, Ferrer Socorro M, Yang K, Battaglia N, Zaman Z, Bennett M, et al. Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70407
BibTeX
@article{GonzalezSaezDiez2026,
author = {Gonzalez Saez-Diez, Enrique and Ferrer Socorro, Monica and Yang, Kathryn and Battaglia, Nicole and Zaman, Zainab and Bennett, Mariko and Vanderver, Adeline and Lee, Pui Y and Henderson, Lauren A and Andzelm, Milena M and Ebrahimi-Fakhari, Darius},
title = {Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70407}
}
EUVIMED